A pilot study of Biotene OralBalance® gel for oral care in mechanically ventilated preterm neonates

Beatrice M. Stefanescu, Caroline Hétu, James C. Slaughter, T. Michael O'Shea, Avinash K. Shetty

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Neonatal ventilator-associated pneumonia (VAP) is associated with increased morbidity and mortality. In adults on mechanical ventilation, timed oral care decreases the frequency of VAP, but this approach has not been studied in neonates. Objectives: To evaluate the feasibility of a randomized trial of timed oral care with Biotene OralBalance® gel and estimate the required sample size for such a trial. Methods: Infants were eligible for enrollment if they were born before 28. weeks of gestation, and were mechanically ventilated between 7 and 10 postnatal days. Infants were randomized to receive timed oral care with Biotene OralBalance® gel or sterile water. All subjects were treated with a standard bundle of procedures to reduce the risk of VAP. Results: We enrolled 41 of 46 eligible infants (89%). Compliance with timed oral care protocol was 97%. No local oral side effects of Biotene OralBalance® gel were observed. There were no significant group differences in mortality or short-term outcomes, except length of hospital stay which was significantly shorter in the Sterile water group (p=0.02). A lower rate of VAP was found in the Biotene group, although the difference was not statistically significant (9/1000 ventilator-days versus 17/1000 ventilator-days in the Sterile water group, respectively; p=0.16). Conclusions: The results of this pilot study support the feasibility of a randomized trial of timed oral care with Biotene OralBalance® gel for prevention of VAP in mechanically ventilated neonates.

Original languageEnglish
Pages (from-to)33-39
Number of pages7
JournalContemporary Clinical Trials
Volume35
Issue number2
DOIs
Publication statusPublished - 01-07-2013
Externally publishedYes

Fingerprint

Ventilator-Associated Pneumonia
Gels
Newborn Infant
Mechanical Ventilators
Water
Length of Stay
Mortality
Artificial Respiration
Sample Size
Biotene
Morbidity
Pregnancy

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Stefanescu, Beatrice M. ; Hétu, Caroline ; Slaughter, James C. ; O'Shea, T. Michael ; Shetty, Avinash K. / A pilot study of Biotene OralBalance® gel for oral care in mechanically ventilated preterm neonates. In: Contemporary Clinical Trials. 2013 ; Vol. 35, No. 2. pp. 33-39.
@article{6a6a2e93157541ab8cd4c6c7f2b2b1b6,
title = "A pilot study of Biotene OralBalance{\circledR} gel for oral care in mechanically ventilated preterm neonates",
abstract = "Background: Neonatal ventilator-associated pneumonia (VAP) is associated with increased morbidity and mortality. In adults on mechanical ventilation, timed oral care decreases the frequency of VAP, but this approach has not been studied in neonates. Objectives: To evaluate the feasibility of a randomized trial of timed oral care with Biotene OralBalance{\circledR} gel and estimate the required sample size for such a trial. Methods: Infants were eligible for enrollment if they were born before 28. weeks of gestation, and were mechanically ventilated between 7 and 10 postnatal days. Infants were randomized to receive timed oral care with Biotene OralBalance{\circledR} gel or sterile water. All subjects were treated with a standard bundle of procedures to reduce the risk of VAP. Results: We enrolled 41 of 46 eligible infants (89{\%}). Compliance with timed oral care protocol was 97{\%}. No local oral side effects of Biotene OralBalance{\circledR} gel were observed. There were no significant group differences in mortality or short-term outcomes, except length of hospital stay which was significantly shorter in the Sterile water group (p=0.02). A lower rate of VAP was found in the Biotene group, although the difference was not statistically significant (9/1000 ventilator-days versus 17/1000 ventilator-days in the Sterile water group, respectively; p=0.16). Conclusions: The results of this pilot study support the feasibility of a randomized trial of timed oral care with Biotene OralBalance{\circledR} gel for prevention of VAP in mechanically ventilated neonates.",
author = "Stefanescu, {Beatrice M.} and Caroline H{\'e}tu and Slaughter, {James C.} and O'Shea, {T. Michael} and Shetty, {Avinash K.}",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.cct.2013.03.010",
language = "English",
volume = "35",
pages = "33--39",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",
number = "2",

}

A pilot study of Biotene OralBalance® gel for oral care in mechanically ventilated preterm neonates. / Stefanescu, Beatrice M.; Hétu, Caroline; Slaughter, James C.; O'Shea, T. Michael; Shetty, Avinash K.

In: Contemporary Clinical Trials, Vol. 35, No. 2, 01.07.2013, p. 33-39.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A pilot study of Biotene OralBalance® gel for oral care in mechanically ventilated preterm neonates

AU - Stefanescu, Beatrice M.

AU - Hétu, Caroline

AU - Slaughter, James C.

AU - O'Shea, T. Michael

AU - Shetty, Avinash K.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Background: Neonatal ventilator-associated pneumonia (VAP) is associated with increased morbidity and mortality. In adults on mechanical ventilation, timed oral care decreases the frequency of VAP, but this approach has not been studied in neonates. Objectives: To evaluate the feasibility of a randomized trial of timed oral care with Biotene OralBalance® gel and estimate the required sample size for such a trial. Methods: Infants were eligible for enrollment if they were born before 28. weeks of gestation, and were mechanically ventilated between 7 and 10 postnatal days. Infants were randomized to receive timed oral care with Biotene OralBalance® gel or sterile water. All subjects were treated with a standard bundle of procedures to reduce the risk of VAP. Results: We enrolled 41 of 46 eligible infants (89%). Compliance with timed oral care protocol was 97%. No local oral side effects of Biotene OralBalance® gel were observed. There were no significant group differences in mortality or short-term outcomes, except length of hospital stay which was significantly shorter in the Sterile water group (p=0.02). A lower rate of VAP was found in the Biotene group, although the difference was not statistically significant (9/1000 ventilator-days versus 17/1000 ventilator-days in the Sterile water group, respectively; p=0.16). Conclusions: The results of this pilot study support the feasibility of a randomized trial of timed oral care with Biotene OralBalance® gel for prevention of VAP in mechanically ventilated neonates.

AB - Background: Neonatal ventilator-associated pneumonia (VAP) is associated with increased morbidity and mortality. In adults on mechanical ventilation, timed oral care decreases the frequency of VAP, but this approach has not been studied in neonates. Objectives: To evaluate the feasibility of a randomized trial of timed oral care with Biotene OralBalance® gel and estimate the required sample size for such a trial. Methods: Infants were eligible for enrollment if they were born before 28. weeks of gestation, and were mechanically ventilated between 7 and 10 postnatal days. Infants were randomized to receive timed oral care with Biotene OralBalance® gel or sterile water. All subjects were treated with a standard bundle of procedures to reduce the risk of VAP. Results: We enrolled 41 of 46 eligible infants (89%). Compliance with timed oral care protocol was 97%. No local oral side effects of Biotene OralBalance® gel were observed. There were no significant group differences in mortality or short-term outcomes, except length of hospital stay which was significantly shorter in the Sterile water group (p=0.02). A lower rate of VAP was found in the Biotene group, although the difference was not statistically significant (9/1000 ventilator-days versus 17/1000 ventilator-days in the Sterile water group, respectively; p=0.16). Conclusions: The results of this pilot study support the feasibility of a randomized trial of timed oral care with Biotene OralBalance® gel for prevention of VAP in mechanically ventilated neonates.

UR - http://www.scopus.com/inward/record.url?scp=84877891849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877891849&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2013.03.010

DO - 10.1016/j.cct.2013.03.010

M3 - Article

C2 - 23608625

AN - SCOPUS:84877891849

VL - 35

SP - 33

EP - 39

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

IS - 2

ER -